ID Clinical Research Fellow (Geneva University Hospital)
UTI’s. Gram-neg bacteria.
Passionate about advancing knowledge, contributing to impactful research in ID management.
Personal Antibiogramm:
Dedicated S, Curious S, stress R, self confidence I (sdd)
Laura Cordes
How do you diagnose and treat CBP? from practice to consensus an ESGUTI project 🦠 #UTIsky, #ESGUTI
A study lead by our amazing Dutch colleagues and UTI researchers to map current approaches worldwide!
@merellambregts.bsky.social @manubilsen.bsky.social
forms.office.com/e/33dnZTgcHK
☀️ Don’t forget to sign for our next WEBINAR “Expert perspectives on Methenamine Hippurate for UTI prevention” ☀️
🔜 24th June 13:00 CET
✍️ escmid.wufoo.com/forms/r1ijmo...
🥳 We are so excited to welcome you to another great ESGUTI webinar! Don’t miss out!
#ESGUTI #IDSky #UTISky
Sign up now for our next ESGUTI webinar on June 24th! It’s gonna be AMAZING!!! 🥳🤩 #ESGUTI #IDSky #UTISky #ESCMID
🆕🔥 State of the art review article @cmicomms.bsky.social
Approach to Clostridioides difficile Diarrheal Infection ( CDI)
Excellent discussions about the management of CDI #IDsky #mustread
www.sciencedirect.com/science/arti...
📣 Systematic review by @lcordes.bsky.social, @bwtrautner.bsky.social, @merellambregts.bsky.social et al assessing evidence for long #antibiotic durations in chronic bacterial #prostatitis. Spoiler: there isn’t much.
#IDSky #clinmicro #UroSky #MedSky #OA #AMR
www.sciencedirect.com/science/arti...
Laura Cordes
ESGUTI Study Group (ESCMID)
ESGUTI Study Group (ESCMID)
Antibiotic Steward 🅱️C🆔🅿️🌟
CMI Communications
Optimal antibiotic durations for chronic bacterial prostatitis (CBP) are unknown; current guidelines recommend 4–12 weeks.To systematically review the…
